Mechanisms of homocysteine-induced oxidative stress

被引:339
作者
Tyagi, N [1 ]
Sedoris, KC [1 ]
Steed, M [1 ]
Ovechkin, AV [1 ]
Moshal, KS [1 ]
Tyagi, SC [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40202 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2005年 / 289卷 / 06期
关键词
NADPH oxidase; thioredoxin; nitric oxide; protease-activated receptor; nitric oxide synthase; 2; 7 '-dichlorofluorescein diacetate; asymmetric dimethylarginine; microvascular endothelial cells;
D O I
10.1152/ajpheart.00548.2005
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289: H2649-H2656, 2005. First published August 5, 2005; doi:10.1152/ajpheart. 00548.2005. -Hyperhomocysteinemia decreases vascular reactivity and is associated with cardiovascular morbidity and mortality. However, pathogenic mechanisms that increase oxidative stress by homocysteine (Hcy) are unsubstantiated. The aim of this study was to examine the molecular mechanism by which Hcy triggers oxidative stress and reduces bioavailability of nitric oxide (NO) in cardiac microvascular endothelial cells (MVEC). MVEC were cultured for 0 - 24 h with 0 - 100 mu M Hcy. Differential expression of protease-activated receptors (PARs), thioredoxin, NADPH oxidase, endothelial NO synthase, inducible NO synthase, neuronal NO synthase, and dimethylarginine-dimethylaminohydrolase (DDAH) were measured by real-time quantitative RT-PCR. Reactive oxygen species were measured by using a fluorescent probe, 2',7'-dichlorofluorescein diacetate. Levels of asymmetric dimethylarginine (ADMA) were measured by ELISA and NO levels by the Griess method in the cultured MVEC. There were no treatment. However, Hcy significantly induced inducible NO synthase alterations in the basal NO levels with 0 - 100 mu M Hcy and 0-24 h of and decreased endothelial NO synthase without altering neuronal NO synthase levels. There was significant accumulation of ADMA, in part because of reduced DDAH expression by Hcy in MVEC. Nitrotyrosine expression was increased significantly by Hcy. The results suggest that Hcy activates PAR-4, which induces production of reactive oxygen species by increasing NADPH oxidase and decreasing thioredoxin expression and reduces NO bioavailability in cultured MVEC by 1) increasing NO2-tyrosine formation and 2) accumulating ADMA by decreasing DDAH expression.
引用
收藏
页码:H2649 / H2656
页数:8
相关论文
共 41 条
[1]
Relationships between homocysteine, Factor VIIa, and thrombin generation in acute coronary syndromes [J].
Al-Obaidi, MK ;
Philippou, H ;
Stubbs, PJ ;
Adami, A ;
Amersey, R ;
Noble, MM ;
Lane, DA .
CIRCULATION, 2000, 101 (04) :372-377
[2]
Protease activated receptors in cardiovascular function and disease [J].
Barnes, JA ;
Singh, S ;
Gomes, AV .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 263 (01) :227-239
[3]
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[4]
Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults [J].
Bellamy, MF ;
McDowell, IFW ;
Ramsey, MW ;
Brownlee, M ;
Bones, C ;
Newcombe, RG ;
Lewis, MJ .
CIRCULATION, 1998, 98 (18) :1848-1852
[5]
ARTERIAL ENDOTHELIAL BARRIER DYSFUNCTION - ACTIONS OF HOMOCYSTEINE AND THE HYPOXANTHINE-XANTHINE OXIDASE FREE-RADICAL GENERATING-SYSTEM [J].
BERMAN, RS ;
MARTIN, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (04) :920-926
[6]
Expression of and functional responses to protease-activated receptors on human eosinophils [J].
Bolton, SJ ;
McNulty, CA ;
Thomas, RJ ;
Hewitt, CRA ;
Wardlaw, AJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (01) :60-68
[7]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]
Brass LF, 1997, THROMB HAEMOSTASIS, V78, P234
[9]
Effect of homocysteine on the production of nitric oxide in endothelial cells [J].
Chow, K ;
Cheung, F ;
Lao, TTH ;
O, K .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (10) :817-818
[10]
Protease-activated receptors: sentries for inflammation? [J].
Cocks, TM ;
Moffatt, JD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) :103-108